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Abstract
Selection of mammalian high-producer cell lines remains a major challenge for the biopharmaceutical manufacturing
industry. Ribosomal RNA (rRNA) genes encode the major component of the ribosome but many rRNA gene copies are not
transcribed [1–5] due to epigenetic silencing by the nucleolar remodelling complex (NoRC) [6], which may limit the cell’s full
production capacity. Here we show that the knockdown of TIP5, a subunit of NoRC, decreases the number of silent rRNA
genes, upregulates rRNA transcription, enhances ribosome synthesis and increases production of recombinant proteins.
However, general enhancement of rRNA transcription rate did not stimulate protein synthesis. Our data demonstrates that
the number of transcriptionally competent rRNA genes limits efficient ribosome synthesis. Epigenetic engineering of
ribosomal RNA genes offers new possibilities for improving biopharmaceutical manufacturing and provides novel insights
into the complex regulatory network which governs the translation machinery in normal cellular processes as well as in
pathological conditions like cancer.
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Introduction
On the way from DNA to product translation is a major
bottleneck which may limit the specific productivity of mammalian
production cell lines. Cells can upregulate the rate of protein
synthesis either by increasing the translational efficiency of existing
ribosomes or by increasing the capacity of translation through the
production of new ribosomes (ribosome biogenesis) [7]. With
about 80% of total nuclear transcription being dedicated to the
synthesis of ribosomal RNA (rRNA), ribosome biogenesis is one of
the major metabolic activity of mammalian cells. Ribosome
assembly occurs within the nucleolus and requires coordinated
expression of four rRNAs (45S pre-rRNA, which is subsequently
processed into 18S, 5.8S, 28S and 5S rRNA) and about 80
ribosomal proteins (r-proteins) [8]. 45S pre-rRNA is transcribed in
the nucleolus by polymerase I (Pol I), 5S RNA is transcribed by Pol
III at the nucleolar periphery and then imported into the nucleolus
[9] and r-proteins are transcribed by Pol II. Thus, ribosome
biogenesis requires orchestration of transcription by different
polymerases operating in different compartments. In mammalian
cells, these processes are largely unknown.
Transcription of 45S pre-rRNA is the key step of ribosome
biogenesis. Mammalian haploid genomes contain about 200
ribosomal RNA genes of which only a fraction is transcribed at
any given time, while the rest remains silent [4,10]. Active and
silent genes are distinct with respect to chromatin configuration:
active genes have a euchromatic structure, whereas silent genes are
heterochromatic. The promoter of active rRNA genes is free of
CpG methylation and is associated with acetylated histones. The
opposite is true of silent genes [1,2,11]. Recent results indicate that
the key determinant of rDNA silencing is NoRC (nucleolar
remodeling complex). NoRC consists of TIP5 (TTF-1-interacting
protein 5) and the ATPase SNF2 h [6]. NoRC binds to the rDNA
promoter of silent genes and represses rDNA transcription
through histone-modifying and DNA-methylating activities [1–4].
Results
The presence of transcriptionally silent rRNA genes raises the
question as to whether this represents a limiting factor for the
synthesis of rRNA and the production of ribosomes. It has been
hypothesized that cells can modulate rDNA transcription levels by
altering the transcriptional activity of each gene and/or by altering
the number of active genes [12]. However, a satisfying correlation
between 45S pre-rRNA synthesis levels and the number of rRNA
genes has not been found. For instance, in S. cerevisiae, reducing the
number of rRNA genes by about two thirds did not affect total
rRNA production [13]. Similarly, maize inbred lines and aneuploid
chicken cells, containing different numbers of rRNA copies
displayed the same levels of rRNA transcription [14,15]. With the
aim of engineering cells for increased synthesis of recombinant
proteins, we determined whether a decrease in the number of silent
rRNA genes enhances 45S pre-rRNA synthesis and, as conse-
quence, also stimulates ribosome biogenesis and increases the
number of translation-competent ribosomes. Therefore, we used
RNA interference to knock down TIP5 expression and constructed
stably transgenic shRNA-expressing NIH/3T3 or miRNA-express-
ing HEK293T and CHO-K1 using shRNA/miRNA sequences
specific for two different regions of TIP5 (TIP5-1 and TIP5-2).
Stable cell lines expressing scrambled shRNA and miRNA
sequences were used as control. There were two reasons for
producing stable cell lines rather than performing transient
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TIP5 sequences. First, the loss of repressive epigenetic marks like
CpG methylation is a passive mechanism, requiring multiple cell
divisions. Second, even though HEK293T cells can be transfected
relatively easily, the poor transfection efficiency of NIH/3T3 and
CHO-K1 cells would compromise subsequent analyses of endog-
enous rRNA, ribosome levels and cell growth properties. To
determine the efficiency of TIP5 knockdown in the selected clones,
we measured TIP5 mRNA levels by quantitative and semiquanti-
tative reverse-transcriptase-mediated PCR (Fig. 1a,b). TIP5
expression decreased about 70–80% in NIH/3T3/shRNA-TIP5-
1 and -2 cells when compared to control cells (Fig. 1a). A similar
reduction in TIP5 mRNA levels was observed in stable HEK293T.
TIP5 mRNA levels in CHO-K1-derived cells could be measured
only by semiquantitative PCR (Fig. 1b) but the reduction of TIP5
mRNA was similar to that of stable NIH/3T3 and HEK293T cells.
Consistent with this, Western blot analysis of stable NIH/3T3 and
HEK293T cells indicated a strong reduction of TIP5 protein levels
(Fig. 1c). These results demonstrate that the established cell lines
contain low levels of TIP5.
CpG methylation of the mouse rDNA promoter impairs
binding of the basal transcription factor UBF, and the formation
of preinitiation complexes is prevented [11]. In NIH/3T3 cells
about 40% to 50% of rRNA genes contain CpG-methylated
sequences and are transcriptionally silent [11]. The sequences and
CpG density of the rDNA promoter in humans, mice and Chinese
hamsters differ significantly. In humans, the rDNA promoter
contains 23 CpGs, while in mice and Chinese hamsters there are 3
and 8 CpGs, respectively (Fig. 2a). To verify that TIP5
knockdown affects rDNA silencing, we determined the rDNA
methylation levels by measuring the amount of meCpGs in the
CCGG sequences. Genomic DNA was HpaII-digested, and
resistance to digestion (i.e. CpG methylation) was measured by
quantitative real-time PCR using primers encompassing HpaII
sequences (CCGG) [1]. There was a decrease in CpG methylation
within the promoter region of a the majority of rRNA genes in all
TIP5 knock-down cell lines, underscoring the key role of TIP5 in
promoting rDNA silencing (Fig. 2a). To determine whether a
decrease in the number of silent genes affects the amounts of the
rRNA transcript, we measured 45S pre-rRNA synthesis by qRT-
PCR using primers that encompassed the first rRNA processing
site. As expected, in both TIP5-depleted NIH/3T3 and
HEK293T cells, an enhancement of rRNA production was
detected (Fig. 2b). rRNA transcription in CHO-K1 cells could
Figure 1. TIP5 knockdown. a. qRT-PCR of TIP5 mRNA of NIH/3T3 cells stably expressing shRNA-TIP5-1 and TIP5-2 sequences and of HEK293T cells
stably expressing miRNA-TIP5-1 and TIP5-2 sequences. Data were normalized to GAPDH mRNA levels. Data are from two independent experiments.
b. Semiquantitative RT-PCR of TIP5 mRNA of stable shRNA-TIP5-1/2 NIH/3T3, miRNA-TIP5-1/2 HEK293T and miRNA-TIP5-1/2 CHO-K1 cells. As control,
RT-PCR of GAPDH mRNA is shown. Data are from two independent experiments. c. TIP5-specific Western blot analysis of stable shRNA-TIP5-1/2 NIH/
3T3 and miRNA-TIP5-1/2 HEK293T cells. CHO-K1 cells could not be analyzed because the anti-TIP5 antibody does not recognize hamster TIP5. To
normalize protein loading, the levels of UBF were monitored using an anti-UBF antibody.
doi:10.1371/journal.pone.0006653.g001
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for this cell line. These results indicate that TIP5 knockdown and a
decrease in rDNA silencing enhances rRNA production.
Synthesis of rRNA is the first event in ribosome biogenesis and
is tightly regulated by the activity of cellular metabolism [8,16].
Conditions compromising cellular metabolism such as starvation,
toxic lesions, aging, viral infections and cancer downregulate
rDNA transcription. Conversely, rDNA transcription is upregu-
lated upon reversal of such conditions and by agents that stimulate
growth. To determine whether a decrease in the number of silent
rRNA genes affects cellular proliferation, we compared the
proliferation rate of TIP5-depleted cells and control cells
(Fig. 2c). Previous data indicated that cells overexpressing TIP5
grow more slowly than parental cell lines [17]. Here we show that
both NIH/3T3 and CHO-K1 cells, expressing miRNA-TIP5
sequences, proliferate at a faster rate than the control cells,
suggesting that a decrease in the number of silent rRNA genes
does have an impact on cell metabolism. In contrast, TIP5
depletion in HEK293T did not significantly affect cell prolifera-
tion, probably because these cells had already reached their
maximum rate of proliferation. These data indicate that depletion
of TIP5 and a consequent decrease in rDNA silencing have the
potential to enhance cell proliferation.
In mammalian cell cultures, the rate of protein synthesis is an
important parameter, which is directly related to the product yield.
To determine whether depletion of TIP5 and a consequent
decrease in rDNA silencing increases the number of translation-
competent ribosomes in the cell, we initially measured the levels of
cytoplasmic rRNA. In the cytoplasm, most of the RNA consists of
processed rRNAs assembled into ribosomes. As shown in Fig. 3a,
all TIP5-depleted cell lines contained more cytoplasmic RNA per
cell, suggesting that these cells produce more ribosomes. Also,
analysis of the polysome profile showed that TIP5-depleted cells
contained more ribosome subunits (40S, 60S and 80S) compared
to control cells (17.060.5% and 50.062%, in HEK293T and
CHO-K1, respectively; Fig. 3b). To determine whether depletion
Figure 2. TIP5 depletion enhances rRNA production. a. Depletion of TIP5 decreases CpG methylation of rDNA promoters. Diagram of a mouse,
human and Chinese hamster rDNA promoter regions including the HpaII (H) sites analyzed. Black circles indicate CpG dinucleotides. Arrows represent
the primers used to amplify HpaII-digested DNA. rDNA CpG methylation levels were measured in NIH/3T3, HEK293T and CHO-K1 cells stably
expressing shRNA- and/or miRNA-TIP5-1/2 and control sequences. Data represent the amounts of HpaII-resistant rDNA normalized to the total rDNA
calculated by amplification with primers encompassing DNA sequences lacking HpaII-sites and undigested DNA. Data are from two independent
experiments. b. Depletion of TIP5 enhances rRNA synthesis. qRT-PCR-based 45S pre-rRNA levels of stable NIH/3T3 and HEK293T cell lines were
normalized to GAPDH mRNA levels. Data are from two independent experiments. c. Growth curves of NIH/3T3, HEK293T and CHO-K1 cells stably
expressing miRNA-TIP5 and control sequences. Data are from two independent experiments.
doi:10.1371/journal.pone.0006653.g002
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K1 cells. Data represent the average of two experiments performed in triplicate. b. Polysome profile of stable HEK293T and CHO-K1 cell lines. The data
show one representative experiment out of two independent experiments. c. Depletion of TIP5 enhances production of recombinant proteins. SEAP
expression of stable NIH/3T3, HEK293T and CHO-K1 cell lines engineered with the constitutive SEAP expression vector pCAG-SEAP. Data are from
three independent experiments. d. Luciferase expression of stable NIH/3T3 and HEK293T cell lines engineered with the constitutive luciferase
expression vector pCMV-luciferase. Data are from two independent experiments. e. Relative SEAP transcript levels of stable HEK293T cells transfected
with a constitutive SEAP expression vector. Values were normalized to GAPDH mRNA levels. Data are from two independent experiments.
doi:10.1371/journal.pone.0006653.g003
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protein production, we transfected stable TIP5-depleted NIH/
3T3, HEK293T and CHO-K1 derivatives with expression vector
promoting constitutive expression of the human placental secreted
alkaline phosphatase SEAP (pCAG-SEAP) or luciferase (pCMV-
luciferase) (Fig. 3c,d). Quantification of protein production after
48 h revealed a two- to four-fold increase in both SEAP and
luciferase production in TIP5-depleted cells compared to the
control cell lines, indicating that TIP5-depletion increases
heterologous protein production. As expected, no changes in
reporter gene mRNA levels could be detected in stable HEK293T
(Fig. 3e), NIH/3T3 and CHO-K1 cells (data not shown). All
these results show that a decrease in the number of silent rRNA
genes enhances ribosome synthesis and increases the potential of
the cells to produce recombinant proteins.
Ribosome production requires coordinated expression and
assembly of rRNAs and r-proteins. To determine whether an
increase in the rate of 45S pre-rRNA transcription of each rRNA
gene is sufficient to enhance ribosome production and heterolo-
gous protein synthesis, we transfected SEAP-expressing HEK293T
and HeLa cells with a constitutive expression vector encoding the
basal transcription factor UBF or the parental control vector. UBF
binds to active rRNA genes, promotes transcription initiation and
regulates the elongation rate [11,18]. As expected, UBF stimulates
45S pre-rRNA synthesis in a dose-dependent manner (Fig. 4a).
To determine whether a higher rRNA transcription rate enhances
the synthesis of recombinant proteins, we profiled SEAP
production. As shown in Fig. 4b, overexpression of UBF did
not stimulate SEAP production in HEK293T and HeLa cells,
suggesting that a higher synthesis rate of all rRNA genes is not
enough to enhance heterologous protein production capacity of
mammalian cells. Also, polysome profile analysis of UBF-
overexpressing HEK293T cells, indicated a decrease in the
ribosome content compared to the control cells (22.061.0%;
Fig. 4c). This result suggests that enhancement of the rate of 45S
pre-rRNA synthesis, mediated by overexpression of UBF, is not
coordinated with ribosome biogenesis, thus probably generating
dysfunctional and incomplete ribosomes. Our data demonstrate
that a decrease in the number of transcriptionally silent rRNA
genes stimulates ribosome production, while an increase in the rate
of rRNA transcription did not.
Discussion
Control of the translational machinery and an increase in the
rate of cellular protein synthesis are major challenges in
biopharmaceutical manufacturing. Different metabolic engineer-
ing strategies have been designed to improve the productivity of
mammalian host cell lines, such as transcription engineering using
trigger-inducible expression systems, translation engineering
consisting of improving ribosomal entry and translation initiation
and controlled proliferation technology which blocks proliferation
at high cell density to allow an extended period of high
productivity [19–22]. Here we show that engineering the
epigenetic state of rRNA genes enhances the productivity of
recombinant proteins. Depletion of TIP5 is a straightforward
metabolic engineering strategy to increase production of protein
pharmaceuticals, which may speed-up biopharmaceutical manu-
facturing and/or drive production economics into a viable range.
To the best of our knowledge, this is the first time that an
engineered decrease in the number of silent rRNA genes could be
correlated with enhanced production of rRNA and ribosomes and
consequently with higher productivity of mammalian cells. Thus,
our data indicate a link between the amounts of transcriptionally
competent rRNA genes with the metabolic activity of the cell. A
sustained increase in the rates of protein synthesis is required
during normal cellular process such as organ regeneration, but
also under pathological conditions such as tumor development
[23,24]. Cancer cells upregulate rRNA transcription to meet the
demand for the increased production of ribosomes and for protein
synthesis of the rapidly proliferating tumors. It was recently shown
that several tumor types contain rRNA genes with a low density of
CpG methylation [25–27]. However, a correlation between rDNA
hypomethylation and ribosome biogenesis has not been found. We
therefore provide an explanation of how impairment of rDNA
silencing contributes to the aberrant ribosome biogenesis that is
essential for the active growth of the tumor. Our data link rRNA
gene silencing, proliferation and productivity and so offer a new
strategy to improve biopharmaceutical production of important
protein therapeutics. They also provide new insights into the
complex regulatory network that governs the translation machin-
ery in normal cells and in pathological processes like cancer.
Methods
Plasmids
pCMV-UBF was kindly provided by Ingrid Grummt. pCMV-
TAP-tag contains TAP-tag sequences transcribed under control of
cytomegalovirus immediate early promoter.
Stable cell lines
NIH/3T3 cells were stably transfected with plasmids expressing
shRNA TIP5-1 (59-GGACGATAAAGCAAAGATGTTCAAGA-
GACATCTTTGCTTTATCGTCC-39) and TIP5-2 (59-GCAG-
CCCAGGGAAACTAGATTCAAGAGATCTAGTTTCCCTG-
GGCTGC-39) sequences under control of the H1 promoter.
HEK293T and CHO-K1 cells were stably transfected with
plasmids expressing control miRNA or miRNA sequences
targeting TIP5 (TIP5-1: 59- GATCAGCCGCAAACTCCTCT-
GAGTTTTGGCCACTGACTGACTCAGAGGATTGCGGCT-
GAT-39; TIP5-2: 59- GCAAAGATGGGATCAGTTAAGGGT-
TTTGGCCACTGACTGACCCTTAACTTCCCATCTTTG-39)
according to the Block-iT Pol II miR RNAi system (Invitrogen).
Transcription analysis
45S pre-rRNA transcription was measured by qRT-PCR in
accordance with the standard procedure and using the Universal
Master mix (Diagenode). Primer sequences used to detect mouse
and human 45S pre-rRNA and GAPDH have been described
before [1,2].
CpG methylation analysis
Methylation of mouse and human rDNA was measured as
described previously [1,28]. Primers used for analysis of rDNA
methylation in CHO-K1 cells were: -168/-149 forward 59-GAC-
CAGTTGTTGCTTTGATG-39; -10/+10 reverse 59-GCGT-
GTCAGTACCTATCTGC-39; -100/-84 forward 59-TCCCG-
ACTTCCAGAATTTC-39.
Protein production
Protein production was assessed 48h after transfection of a
constitutive SEAP (pCAG-SEAP) or luciferase expression vector
(pCMV-Luciferase). SEAP production was measured by a p-
nitrophenyphospate-based light-absorbance time course [29].
Luciferase profiling was performed according to the manufactur-
er’s instructions (Applied biosystems, Tropix
H luciferase assay kit).
Values were normalized to cell numbers and to transfection
efficiency. Transfection efficiency was measured by flowcytometric
Epigenetic Engineering
PLoS ONE | www.plosone.org 5 August 2009 | Volume 4 | Issue 8 | e6653Figure 4. Enhancement of the rRNA transcription rate does not increase recombinant protein synthesis. a. qRT-PCR of 45S rRNA levels
in HEK293T and HeLa following expression of increasing amounts of UBF (pCMV-UBF). rRNA levels were normalized to GAPDH mRNA quantities. Data
are from two independent experiments. b. SEAP expression of HEK293T and HeLa cells co-transfected with pCAG-SEAP and either pCMV-UBF or
pCMV-TAP-tag (control). Data are from two independent experiments. c. Polysome profile of HEK293T cells transfected with either pCMV-UBF or
pCMV-TAP-tag (control). The data show one representative experiment out of two independent experiments.
doi:10.1371/journal.pone.0006653.g004
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C1, Clontech). All experiments were performed in triplicate and
were repeated three times.
Growth curves
10
5 cells were seeded per well of a 6-well plate and each day
cells were trypsinized, collected and counted with Casy
H Cell
Counter (Schaerfe System). All cell lines showed similar viability.
Experiments were performed in duplicates and repeated twice.
Polysome profile
Cells were treated with cycloheximide (100 mg/ml, 10 min) and
lysed in 20 mM Tris-HCl, pH7.5, 5 mM MgCl2, 100 mM KCl,
2.5 mM DTT, 100 mg/ml cycloheximide, 0.5% NP40, 0.1 mg/ml
heparin and 200 U/ml RNAse inhibitor at 4uC. After centrifu-
gation at 8,000 g for 5 min, the supernatants were loaded onto a
15%–45% sucrose gradient and centrifuged for 4 h at 28,000 rpm
at 4uC. 200 ml fractions were collected and the optical density of
individual fractions was measured at 260 nm. Quantifications
were performed by comparing the total absorbance corresponding
to 80S (HEK293T) and 60-80S (CHO-K1) peaks.
Cytoplasmatic RNA measurements
Cells were tripsinized and counted in triplicates with Casy
H Cell
Counter (Schaerfe System). Triplicates of 10
6 cells were washed
with PBS, lysed in cytoplasmic buffer (10 mM HEPES, pH 7.6,
60 mM KCl, 1 mM EDTA, 0.075% Triton X-100, 1 mM DTT)
and centrifuged at 8000 g. RNA was isolated from the lysate
supernatants using TRIzol
H (Invitrogen) according to the manu-
facturer’s instructions and quantified in triplicate by measuring
absorbance at 260 nm.
Antibodies
The Anti-TIP5 antibody was purchased from Diagenode, the
Anti-UBF antibody from Santa Cruz.
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